Comment on “Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis”
Richárd Kellermayer(Baylor College of Medicine), Harland S. Winter(Massachusetts General Hospital), Gerald Holtmann(Royal Adelaide Hospital), Parambir S. Dulai(Northwestern Medicine), Ayesha Shah(Translational Research Institute), James H. Tabibian(Adventist Health Glendale), Kevin M. Johnson(Yale University), Peter Lewindon(The University of Queensland), Cynthia W. Buness(Pancreatic Cancer Action Network), Shamita B. Shah(Ochsner Medical Center), Ahmad H. Ali(University of Missouri Hospital)
Cited by 2
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
|Hepatology|2017|1.9k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k